ACRSNasdaq

Aclaris Therapeutics, Inc.

Pharmaceutical Preparations · DE · CIK 1557746

Aclaris Therapeutics develops prescription drug products, focusing on obtaining and maintaining favorable coverage and reimbursement

$603M

Market cap

$5.29

Last close

+5.4%

+7.5%

3.2M

Volume

Price · last 40 sessions+16.8%

May 4L $4.10 · H $5.29Jun 30

272

Total filings

Jun 4, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance